FHS World 2026 opened in Dubai with approximately 1,000 hospitality investment professionals gathered from 50 countries, ...
AbbVie announced that the primary results from the ongoing Phase 2 APEX Part B Dose-Regimen-Finding Study, evaluating zumilokibart, in adult patients with moderate to severe atopic dermatitis (AD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results